Document is current
Any future updates will be listed below
-
Authors
Larrouy-Maumus, Gerald https://orcid.org/0000-0001-6614-8698
Dortet, Laurent
Nix, Ilka D.
Maier, Thomas
Oberheitmann, Boris
Sparbier, Katrin
Kostrzewa, Markus
-
Funding
Funding for this research was provided by:
Wellcome Trust (105603/Z/14/Z)
- License Information
-
More Information
Article History
Received: 1 February 2023
Accepted: 10 March 2023
First Online: 27 March 2023
Declarations
:
: None required.
: L. D. and G. L-M. are co-inventors of the rapid detection of colistin-resistant bacteria, for which a patent has been filed by Imperial Technology Transfer (WO2018158573A1 METHOD OF DETECTION). B. O., I. D. N., K. S., M. K., and T. M. are employees of Bruker Daltonics GmbH & Co. KG, the manufacturer of the MALDI-TOF MS system used in this study, MBT Lipid Xtract™ Kit and MBT HT LipidART Module. The remaining authors have no conflict of interest to declare.
